Polar Asset Management Partners Inc. Purchases New Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Polar Asset Management Partners Inc. bought a new position in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 84,400 shares of the company's stock, valued at approximately $2,288,000. Polar Asset Management Partners Inc. owned approximately 0.35% of OrthoPediatrics as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in KIDS. Portolan Capital Management LLC increased its holdings in OrthoPediatrics by 66.2% in the 3rd quarter. Portolan Capital Management LLC now owns 308,099 shares of the company's stock worth $8,353,000 after buying an additional 122,770 shares in the last quarter. Centiva Capital LP bought a new stake in shares of OrthoPediatrics in the third quarter worth approximately $319,000. BNP Paribas Financial Markets raised its holdings in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company's stock valued at $94,000 after purchasing an additional 1,929 shares during the last quarter. Quantbot Technologies LP lifted its position in OrthoPediatrics by 42.2% during the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company's stock valued at $157,000 after purchasing an additional 1,712 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in OrthoPediatrics by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 132,434 shares of the company's stock worth $3,590,000 after purchasing an additional 2,661 shares during the last quarter. Institutional investors own 69.05% of the company's stock.

OrthoPediatrics Trading Up 0.3 %

KIDS stock traded up $0.07 during mid-day trading on Friday, reaching $23.17. 258,751 shares of the stock traded hands, compared to its average volume of 168,726. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The stock has a market capitalization of $561.18 million, a PE ratio of -18.78 and a beta of 1.14. OrthoPediatrics Corp. has a one year low of $22.41 and a one year high of $36.23. The business has a 50-day moving average price of $25.89 and a two-hundred day moving average price of $28.93.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Truist Financial dropped their price target on OrthoPediatrics from $34.00 to $28.00 and set a "hold" rating on the stock in a research note on Monday, October 14th. Needham & Company LLC reissued a "buy" rating and issued a $42.00 target price on shares of OrthoPediatrics in a research report on Friday, November 8th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.